Scientists in Australia report this week that they have developed a
powerful software modelling tool, MolSAR, which could have the
potential to reduce drug development costs by up to €28 million per
Dharmacon, a US supplier of RNA and RNA-interference research
products, announced today it has launched Cell Cycle siARRAY, a
collection of ready-to-use siRNA duplexes designed to knock down
112 genes involved in cell cycle regulation.
Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...
Ireland's Elan Corp has inked a deal with Ingenium Pharmaceuticals
of Germany that will see the companies apply Ingenium's functional
genomics technologies to the discovery and development of novel
therapeutics for pain...
British Biotech, once the darling of the UK biotechnology industry
but now suffering the after-effects of a string of major drug
development failures, is having another go at bolstering its
pipeline via a merger with fellow UK company...
Akzo Nobel has opened a new powder coatings factory in Ho Chi Minh
City, Vietnam in partnership with Chang Cheng Securities, marking
the 12th powder coatings site in the Asia Pacific region for the
A series of new flow cytometry products will soon hit the market
with the announcement yesterday from US companies BD Biosciences
and Molecular Probes that, following a recent license agreement, BD
Biosciences Pharmingen has launched...
SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.
The prospect of using chicken eggs as commercial 'biofactories' for
the production of protein-based drugs has moved a step closer with
the announcement of a study showing that transgenic cockerels can
pass on an introduced...
European scientists continue to be strong in areas such as medical
research and chemistry and Europe may produce the highest number of
science graduates but it is lagging behind in biotechnology, still
employs fewer researchers, accounts...
For years, it has been common wisdom in the pharmaceutical industry
that delivery of drugs via the nose only really works if the
compound can be presented in liquid form. One company begging to
differ is Britannia Pharmaceuticals...
Drug target validation has become the critical step in maintaining
profitability for the pharmaceutical industry, claims a new report
from market research company Business Communications. Drug
developers must accelerate identification...
A new approach to identifying patterns in gene expression analysis
has been shown to be more effective than the most popular method in
a joint Penn State and University at Buffalo study, write US
scientists this week.
Amersham Biosciences has launched a new bench-top separations
system for purifying proteins, äKTApilot, which for the first time
allows scientists to carry out process development right through to
small-scale production using a single...
Scientists in the US report this week that they have developed a
new technology that increases the amount of vitamin C in plants,
including grains, by increasing the amount of the enzyme that is
responsible for recycling vitamin C.
US outsourcing company Cardinal Health is to provide alternative
drug formulation development and delivery capabilities for the
biotechnology and pharmaceutical industries, the company announced
The UK Medicines Control Agency has published a new guidance on
best practice in drug labelling and packaging which is part of a
broader Department of Health programme aimed at achieving a 40 per
cent cut in medication errors by 2005....
In its first progress report since adopting the EU strategy on life
sciences and biotechnology in 2002, the European Commission
yesterday indicated that the risk of diverging policies in Member
States could seriously hamper the effectiveness...
UK microbial testing company Celsis International announced this
week that food giant Nestle has selected Celsis' recently launched
milk and cream diagnostic system for its global Research &
Development site in Konolfingen.
Roche Vitamins is to start production of pure epigallocatechin
gallate (EGCG), the active compound in green tea, at a new
production plant in Shanghai. Annual output is expected to be more
than 40 tons.
Amarin corporation this week confirmed that its Swedish subsidiary
Amarin Development AB, as part of an agreement with Watson
Pharmaceuticals, has developed a generic formulation of glipizide
extended release tablets.
"The current confluence of negative factors facing the chemical
manufacturing industry could be called 'the perfect storm',"
said Andrew N. Liveris, president of Dow Chemical company's
Drug development and biomedical company Thuris and Italian
pharmaceutical company Sigma-Tau Industrie Farmaceutiche Riunite on
Monday announced an expansion of their ongoing research
collaboration to develop compounds to combat brain...
An Edinburgh-based marine biotech business has been given a £50,000
(€73 000) boost in its bid to scour tidal areas such as rock pools
to find and develop new drugs and antibiotics, including a new
compound found to be active against...
Swiss life-science company Lonza announced on Tuesday that it is to
strengthen the production of oligonucleotides - an emerging new
class of therapeutics consisting of short nucleic acid chains
interfering in the processing of genetic...
Women are becoming the most attractive target audience for
healthcare companies, claims a new report from market analysts
Datamonitor. A combination of increasing Internet access, a general
interest in health issues among women along...
In the second news of the day on a European life science company,
DSM announced this week that from now on it will supply
technologies and services for the initial development phases of new
medicines - supplementing its existing service...
The US Food and Drug Administration announced this week that it has
accomplished the initial objectives outlined in its ongoing
initiative to modernise the agency's regulation of pharmaceutical
manufacturing and product quality.
Japanese company Kaken Pharmaceutical and US Elitra Pharmaceuticals
said yesterday that they are to collaborate on a multi-year
research project for the discovery and development of novel
AstraZeneca Canada has received approval from the Therapeutic
Products Directorate of Health Canada to market CRESTOR
(rosuvastatin) 10 to 40 mg, a new medicine for the management of
primary high cholesterol (primary hypercholesterolemia),...
Nabi Biopharmaceuticals saw biopharmaceutical product sales -
driven by strong growth in sales of Nabi-HB - reaching record
levels of $89.5 million (€83m) in 2002, a 22 per cent increase from
Danish company Novozymes announced yesterday that the US Department
of Energy (DOE) has approved the third year of funding for
Novozymes' three-year subcontract to develop more cost-efficient
enzymes for ethanol production.
Isis Innovation, the wholly-owned technology transfer company of
Oxford University, reports this week that researchers at the
university's Inorganic Chemistry laboratory have found that they
can intercalate a range of pharmaceutically...
US demand for combinatorial chemistry products and services is set
to increase by more than twelve per cent annually to reach $4
billion (€3.7bn) in 2006, according to a new report from market
analyst the Freedonia group.
US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...
In response to recent news regarding patent litigation surrounding
its drug ribavirin, biopharmaceutical company Ribapharm announced
this week that it believes its patent position to be unchanged by
Schering-Plough's recent action...
Roche Molecular Systems, the in vitro diagnostics element of
Swiss pharmaceutical company Roche said this week that its
supplement to the AMPLICOR(TM) HIV-1 Test, version 1.5 has been
accepted for review by the US Food and Drug Administration...